News
Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.
HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback